Earnings summaries and quarterly performance for METLIFE.
Executive leadership at METLIFE.
Michel A. Khalaf
Detailed
President and Chief Executive Officer
CEO
Adrienne O'Neill
Detailed
Executive Vice President and Chief Accounting Officer
Bill Pappas
Detailed
Executive Vice President and Head of Global Technology and Operations
Eric Clurfain
Detailed
Regional President, Latin America
John D. McCallion
Detailed
Executive Vice President and Chief Financial Officer
Lyndon Oliver
Detailed
Regional President, Asia
Marlene Debel
Detailed
Executive Vice President and Chief Risk Officer
Michael Roberts
Detailed
Executive Vice President and Chief Marketing Officer
Monica Curtis
Detailed
Executive Vice President and Chief Legal Officer
Nuria Garcia
Detailed
Regional President, EMEA
Ramy Tadros
Detailed
Regional President, U.S. Business and Head of MetLife Holdings
Shurawl Sibblies
Detailed
Executive Vice President and Chief Human Resources Officer
Board of directors at METLIFE.
Carla A. Harris
Detailed
Director
Carlos M. Gutierrez
Detailed
Director
Christian Mumenthaler
Detailed
Director
Denise M. Morrison
Detailed
Director
Diana L. McKenzie
Detailed
Director
Jeh C. Johnson
Detailed
Director
Laura J. Hay
Detailed
Director
Mark A. Weinberger
Detailed
Director
R. Glenn Hubbard
Detailed
Chairman of the Board
William E. Kennard
Detailed
Director
Research analysts who have asked questions during METLIFE earnings calls.
Ryan Krueger
KBW
7 questions for MET
Also covers: AFL, AMP, ASGN +14 more
Suneet Kamath
Jefferies
6 questions for MET
Also covers: AFL, AMP, BHF +12 more
Wesley Carmichael
Autonomous Research
6 questions for MET
Also covers: ACGL, AFL, BHF +16 more
Joel Hurwitz
Dowling & Partners Securities, LLC
5 questions for MET
Also covers: AFL, CNO, CRBG +9 more
Thomas Gallagher
Evercore
5 questions for MET
Also covers: AFL, AMP, BHF +13 more
Alex Scott
Barclays PLC
3 questions for MET
Also covers: ACGL, AFL, AIG +29 more
Elyse Greenspan
Wells Fargo
3 questions for MET
Also covers: ACGL, AFL, AHL +30 more
Jamminder Bhullar
JPMorgan Chase & Co.
3 questions for MET
Also covers: ACGL, AFL, ALL +13 more
Cave Montazeri
Deutsche Bank
2 questions for MET
Also covers: ACGL, AHL, AJG +4 more
Jimmy Bhullar
JPMorgan Chase & Co.
2 questions for MET
Also covers: ACGL, AFL, ALL +10 more
Tom Gallagher
Evercore ISI
2 questions for MET
Also covers: AMP, PFG, UNM
Wilma Burdis
Raymond James Financial
2 questions for MET
Also covers: AFL, ALTI, AMP +12 more
Wilma Jackson Burdis
Raymond James
2 questions for MET
Also covers: AFL, ALTI, AMP +12 more
John Barnidge
Piper Sandler
1 question for MET
Also covers: AFL, AIZ, AMP +15 more
Nick Anido
Wells Fargo & Company
1 question for MET
Also covers: LNC
Recent press releases and 8-K filings for MET.
MetLife completes $10 billion variable annuity risk transfer
MET
M&A
- MetLife completed a $10 billion variable annuity risk transfer transaction with Talcott Resolution Life Insurance Company, reducing portfolio risk and accelerating runoff of legacy U.S. retail blocks.
- The deal incurs expected foregone annual adjusted earnings of $100 million, partially offset by $45 million in annual hedge cost savings.
- MetLife Investment Management will oversee approximately $6 billion of assets under new investment management agreements with Talcott.
- This transaction exemplifies MetLife’s disciplined execution of risk transfer strategies within its closed-block businesses.
Dec 1, 2025, 9:57 PM
MetLife reports Q3 2025 results
MET
Earnings
Share Buyback
- Adjusted earnings of $1.6 billion, or $2.34 EPS, up ~21% YoY, driven by higher variable investment income and volume growth.
- Variable investment income of $483 million, exceeding guidance of $425 million, with private equity returns of 3% for the quarter.
- Segment results: Group Benefits $457 million (+6%), Retirement & Income Solutions $423 million (+15%), Asia $473 million (+36%), Latin America $222 million (+2%), EMEA $89 million (+19%).
- Capital return: $875 million to shareholders in Q3 (dividends $375 million; share repurchases $500 million), bringing YTD buybacks to ~$2.6 billion; secured $12 billion of pension risk transfer in Q4.
- Direct expense ratio improved to 11.6%, below the full-year target of 12.1%, supported by cost discipline and technology investments.
Nov 6, 2025, 2:00 PM
MetLife reports Q3 2025 results
MET
Earnings
Share Buyback
Dividends
- MetLife reported Q3’25 net income of $818 M (EPS $1.22) and adjusted earnings of $1.584 B (EPS $2.37), or $1.566 B ex-notable items (EPS $2.34).
- Segment adjusted earnings ex-notable items: Group Benefits $457 M (+6% YoY), Asia $473 M (+36%), Retirement & Income Solutions $423 M (+15%), EMEA $89 M (+19%), MetLife Holdings $190 M (+12%).
- Holding company cash and liquid assets of $4.9 B at quarter-end; returned ~$875 M to shareholders in Q3 via $500 M buybacks and $375 M dividends; YTD buybacks of $2.6 B through October.
- U.S. Statutory Adjusted Capital of $17.1 B at 9/30/25 (flat QoQ); Japan Solvency Margin ratio 740%; estimated Economic Solvency Ratio of 170–190% for period ending March 2026.
Nov 6, 2025, 2:00 PM
MetLife reports Q3 2025 earnings
MET
Earnings
- MetLife delivered $1,566 million of adjusted earnings ex. total notable items in Q3 2025, up 15% YoY, and $2.34 adjusted EPS, up 21% YoY.
- Broad-based segment growth: Group Benefits earned $457 million (+6%), Retirement & Income Solutions $423 million (+15%), and Asia $473 million (+36%) in Q3 2025.
- Strong balance sheet: total AUM of $633 billion, MetLife Investment Management on a path to $1 trillion AUM, and $4.7 billion capital returned in 2024.
- Continued financial discipline with 2-digit adjusted EPS growth target, 15–17% adjusted ROE goal (from 12–14%), and 100 bps direct expense ratio improvement target.
Nov 6, 2025, 2:00 PM
MetLife reports Q3 2025 earnings results
MET
Earnings
Share Buyback
Dividends
- MetLife delivered $1.6 billion in adjusted earnings, or $2.37 EPS (up 22% YoY; ex-notables EPS of $2.34, +21%), driven by strong investment margins and volume growth. Variable investment income was $483 million, above the $425 million outlook, supported by 3% private equity returns, yielding a 16.7% adjusted ROE ex-notables.
- Core segments posted robust growth: group benefits adjusted earnings of $457 million (+6%) with a 230 bps sequential improvement in non-medical health loss ratio; retirement & income solutions delivered $423 million (+15%) alongside the launch of Chariot Re with ~$10 billion of liabilities; Asia earnings rose 36% to $473 million on 34% constant-currency sales growth.
- Capital management remained disciplined: returned $875 million in Q3 (≈$375 million dividends; $500 million share buybacks), lifting year-to-date buybacks to ~$2.6 billion; holding-company liquidity of $4.9 billion exceeds the $3–4 billion target; on track to close the PineBridge acquisition and VA block sale in Q4.
- Strategic metrics and outlook: 2024 value of new business capital deployment of $3.4 billion earned a 19% IRR with a five-year payback; Q3 direct expense ratio was 11.6% versus 12.1% full-year target; beginning Q4, MetLife Investment Management will be reported as a standalone segment.
Nov 6, 2025, 2:00 PM
MetLife announces Q3 2025 results
MET
Earnings
Share Buyback
Dividends
- Reported adjusted earnings of $1.6 billion, or $2.34 per share, up 21% year-over-year; variable investment income of $483 million exceeded the $425 million outlook, driving an adjusted return on equity of 16.7% and a direct expense ratio of 11.6%.
- Group Benefits adjusted earnings were $457 million, up 6% year-over-year; the non-medical health loss ratio improved by 230 basis points sequentially to 72.5%.
- Retirement & Income Solutions posted $423 million in adjusted earnings, up 15%; launched Chariot Re with an initial $10 billion reinsurance transaction to expand liability origination capacity.
- Asia segment delivered $473 million in adjusted earnings, a 36% increase; sales surged 34%, driven by a 31% increase in Japan and 39% growth in other Asia markets.
- Returned $875 million to shareholders in Q3 (including $375 million of dividends and $500 million of share repurchases); ended the quarter with $4.9 billion of cash and liquid assets, including $700 million earmarked for near-term debt maturities.
Nov 6, 2025, 2:00 PM
MetLife announces Q3 2025 results
MET
Earnings
Share Buyback
Dividends
- MetLife reported 3Q 2025 net income of $818 million, or $1.22 per share, and adjusted earnings of $1.6 billion ($2.37 per share), up 15% and 22% year-over-year, respectively.
- Premiums, fees and other revenues were $12.5 billion, with adjusted PFOs excluding pension risk transfers up 4%.
- Net investment income grew 16% to $6.1 billion, driven by higher variable investment income.
- Return on equity was 13.1%, with an adjusted ROE of 16.9%.
- Returned $875 million to shareholders via share repurchases and dividends and held $4.9 billion in cash and liquid assets at quarter end.
Nov 5, 2025, 9:32 PM
MetLife announces Q3 2025 results
MET
Earnings
Share Buyback
Dividends
- Net income was $818 million, or $1.22 per share, down 36% and 33% year-over-year, respectively.
- Adjusted earnings reached $1.58 billion (up 15% y/y) with adjusted EPS of $2.37 (up 22%) and an adjusted ROE of 16.9%.
- Premiums, fees and other revenues totaled $12.5 billion (flat y/y); adjusted PFOs excluding pension risk transfers rose 4% to $12.5 billion; net investment income was $6.1 billion, up 16%.
- Returned approximately $875 million to shareholders via share repurchases and dividends; holding company cash and liquid assets totaled $4.9 billion at quarter end.
Nov 5, 2025, 9:15 PM
MetLife expands lifetime income access through Alight partnership
MET
Product Launch
- MetLife is collaborating with Alight to offer its Guaranteed Income (MGI) fixed immediate annuities and Retirement Income Insurance® (RII) QLAC deferred annuities on the Alight Worklife platform, reaching nearly 12 million defined contribution plan participants.
- Enabled by the SECURE Act and SECURE 2.0, the partnership addresses growing demand for retirement income—93% of plan sponsors recognize the need for guaranteed solutions and 69% of workers say such income supports a comfortable retirement.
- The integration provides plan sponsors with streamlined administration and educational resources, while participants gain intuitive digital tools and clear guidance to convert savings into predictable monthly income.
Oct 29, 2025, 1:00 PM
MetLife outlines New Frontier strategy and initial H1 performance
MET
New Projects/Investments
M&A
Share Buyback
- MetLife launched its five-year New Frontier strategy in December, building on its capital-light transformation and targeting a 15–17% ROE over the plan horizon.
- Execution in H1 was strong: group benefits sales +9%, RIS liability balances +6% (vs. 3–5% outlook), and Japan sales +29% in Q2; the company also announced the Pinebridge acquisition, a Talcott reinsurance deal and launched Cherry Tree reinsurance.
- The direct expense ratio is slated to improve by 100 bps over five years on an even-yearly basis and stood at 11.8% in H1 2025.
- Retirement Income Solutions growth is cushioned by the cession of $10 B of liabilities to Chariotree, while Bermuda-based Chariot Re (launched with General Atlantic) immediately secured $10 B of third-party capital; Q2 RIS spreads stabilized at ~100 bps.
- International markets remain a growth driver: Asia H1 sales up 10% in Japan and 40% in Korea, LatAm earnings have doubled since the pandemic with a path to $1 B in earnings and the Accelerator digital platform now has 21 partners and 5 M customers, and EMEA earnings are set to exceed the $70–75 M quarterly outlook.
Sep 3, 2025, 3:08 PM
Quarterly earnings call transcripts for METLIFE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more